A day before current Shire PLC employees globally get their new takeda.com email addresses, the acquisition’s most public champion Christophe Weber said he is “excited and confident” about the combined company’s future and Takeda Pharmaceutical Co. Ltd.’s transformation into what he sees as “a global, values-based, R&D-driven biopharmaceutical leader.”
The Japanese firm’s president and CEO told a Tokyo press conference on Jan. 7 that innovation and focus would be...








